Advanced Therapies Europe

Loading

Panel: Emerging tech in CGT – What's next?

03 Sep 2025
Theatre 1
R&D, clinical innovation & translation
  • Cutting edge developments in CRISPR, gene editing and cell engineering
  • The next wave of in vivo and ex vivo gene therapies
  • What breakthroughs are expected to reshape the industry?
Speakers
Åse Rosenqvist, Nordic Cell Therapy Business Unit Lead - Johnson & Johnson
Stefanos Theoharis, Chief Executive Officer - OneChain Therapeutics
David Sourdive, Co-founder, Executive Vice President CMC & Manufacturing - Cellectis